Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Eva Cuzzoni"'
Autor:
Marianna Lucafò, Simona Granata, Erik J. Bonten, Robert McCorkle, Gabriele Stocco, Chiara Caletti, Davide Selvestrel, Alessio Cozzarolo, Chan Zou, Eva Cuzzoni, Andrea Pasini, Giovanni Montini, Giovanni Gambaro, Giuliana Decorti, William Evans, Gianluigi Zaza
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 3, Pp 964-975 (2021)
Abstract To assess whether NLRP3 gene promoter methylation was able to discriminate glucocorticoid (GC)‐resistant from GC‐sensitive idiopathic nephrotic syndrome (INS), patients with minimal change disease (MCD) or focal segmental glomerulosclero
Externí odkaz:
https://doaj.org/article/621e3aaf41544229af7730a3fc8a064f
Autor:
Elisa Piscianz, Erica Valencic, Eva Cuzzoni, Sara De Iudicibus, Elisa De Lorenzo, Giuliana Decorti, Alberto Tommasini
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e85463 (2014)
Tofacitinib (Tofa) is an inhibitor of Janus Kinase 3, developed for the treatment of autoimmune diseases and for the prevention of transplant rejection. Due to its selective action on proliferating cells, Tofa can offer a way to block T cell activati
Externí odkaz:
https://doaj.org/article/c368fa2460f142dba23c19f4c39d15f0
Autor:
Chiara Caletti, Davide Selvestrel, Marianna Lucafò, Simona Granata, Gabriele Stocco, Eva Cuzzoni, Erik J. Bonten, Giovanni Montini, Robert McCorkle, Chan Zou, William E. Evans, Giuliana Decorti, Andrea Pasini, Alessio Cozzarolo, Giovanni Gambaro, Gianluigi Zaza
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 3, Pp 964-975 (2021)
Clinical and Translational Science
Clinical and Translational Science
To assess whether NLRP3 gene promoter methylation was able to discriminate glucocorticoid (GC)-resistant from GC-sensitive idiopathic nephrotic syndrome (INS), patients with minimal change disease (MCD) or focal segmental glomerulosclerosis (FSGS), w
Autor:
Gabriele Stocco, Eva Cuzzoni, Annalisa Marcuzzi, Giovanni Montini, Elena Monti, Marco Pelin, Diego Favretto, Andrea Pasini, Luciana Ghio, Claudio La Scola, Francesca Mencarelli, Giuliana Decorti, William Morello, Raffaella Franca, Marianna Lucafò, Sara De Iudicibus
Publikováno v:
European Journal of Clinical Pharmacology. 75:1675-1683
Purpose: Idiopathic nephrotic syndrome (INS) is the most frequent form of childhood nephrotic syndrome. Steroids represent the best therapeutic option; however, inter-individual differences in their efficacy and side effects have been reported. To da
Autor:
Matteo Bramuzzo, Gabriele Stocco, Eva Cuzzoni, Tania Silvestri, Oriano Radillo, Patrizia Alvisi, Alessandro Ventura, Giuliana Decorti, Stefano Martelossi, Martina Pozzi Mucelli, Adriana Cifù, Martina Fabris, Diego Favretto, Doriana Lacorte, Andrea Taddio, Marianna Lucafò, Samuele Naviglio
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 68:37-44
Objectives: Anti-tumor necrosis factor antibodies have led to a revolution in the treatment of inflammatory bowel diseases (IBD); however, a sizable proportion of patients does not respond to therapy. There is increasing evidence suggesting that trea
Autor:
Alberto Edefonti, Stefano Turolo, Giuliana Decorti, Eva Cuzzoni, Giovanni Montini, Andrea Pasini, Marco Materassi, Marta Lepore, Luciana Ghio, Fabrizio Pugliese, Cristina Malaventura
Publikováno v:
Pharmacogenomics. 17:1227-1233
Aim: of the study was to analyse the impact of SXR rs3842689 polymorphism on the response to corticosteroids in pediatric idiopathic nephrotic syndrome. Patients & methods: 66 children (56 steroid-sensitive, ten steroid-resistant) were studied for SX
Publikováno v:
Current medicinal chemistry. 25(24)
The story of antimalarials as antinflammatory drugs dates back several centuries. Chinin, the extract of the Cinchona bark, has been exploited since the 18th century for its antimalarial and antifebrile properties. Later, during the Second World War,
Autor:
Erasmo Miele, Diego Favretto, Gabriele Stocco, Samuele Naviglio, Marina Aloi, Giuliana Decorti, Eva Cuzzoni, Massimo Martinelli, Arrigo Barabino, Alessandro Ventura, Stefano Martelossi, Claudio Romano, Raffaella Franca, Serena Arrigo, Daniela Knafelz
BACKGROUND: Early-onset inflammatory bowel disease (IBD) is generally aggressive, with a high probability of complications and need of surgery. Despite the introduction of highly effective biological drugs, treatment with azathioprine continues to be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dc6ede0a268b830cb95d32134154641
https://academic.oup.com/ibdjournal/article/23/4/628/4560763
https://academic.oup.com/ibdjournal/article/23/4/628/4560763
Publikováno v:
British Journal of Clinical Pharmacology. 73:651-655
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: In vitro lymphocyte steroid sensitivity has been suggested as a useful tool to predict in vivo response to glucocorticoid treatment in different inflammatory chronic diseases. A correlation between genetic po
Autor:
Elena Monti, S. De Iudicibus, Giovanni Montini, Marco Pelin, Andrea Pasini, Gabriele Stocco, Diego Favretto, Luciana Ghio, Eva Cuzzoni, Giovanni Messina, Giuliana Decorti
Publikováno v:
Clinical pharmacology and therapeutics. 100(3)
The aim of this study was to evaluate the in vitro steroid sensitivity as a predictor of clinical response to glucocorticoids in childhood idiopathic nephrotic syndrome (INS). Seventy-four patients (median age 4.33, interquartile range [IQR] 2.82-7.2